These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26045004)

  • 1. Development and validation of an enzyme-linked immunosorbent assay to measure adalimumab concentration.
    Desvignes C; Edupuganti SR; Darrouzain F; Duveau AC; Loercher A; Paintaud G; Mulleman D
    Bioanalysis; 2015; 7(10):1253-60. PubMed ID: 26045004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Two Different Techniques to Assess Adalimumab Trough Levels in Patients with Crohn's Disease.
    Bodini G; Giannini EG; Furnari M; Marabotto E; Baldissarro I; Del Nero L; Assandri L; Moscatelli A; Savarino V; Savarino E
    J Gastrointestin Liver Dis; 2015 Dec; 24(4):451-6. PubMed ID: 26697571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of an optical biosensor for rapid monitoring of adalimumab in serum of patients with Crohn's disease.
    Bian S; Lu J; Delport F; Vermeire S; Spasic D; Lammertyn J; Gils A
    Drug Test Anal; 2018 Mar; 10(3):592-596. PubMed ID: 28743169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Three Assays to Quantify Infliximab, Adalimumab, and Etanercept Serum Concentrations.
    van Bezooijen JS; Koch BC; van Doorn MB; Prens EP; van Gelder T; Schreurs MW
    Ther Drug Monit; 2016 Aug; 38(4):432-8. PubMed ID: 27120178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An enzyme-linked immunosorbent assay for therapeutic drug monitoring of infliximab.
    Ternant D; Mulleman D; Degenne D; Willot S; Guillaumin JM; Watier H; Goupille P; Paintaud G
    Ther Drug Monit; 2006 Apr; 28(2):169-74. PubMed ID: 16628126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of an enzyme-linked immunosorbent assay to measure free eculizumab concentration in serum.
    Passot C; Desvignes C; Ternant D; Bejan-Angoulvant T; Duveau AC; Gatault P; Paintaud G
    Bioanalysis; 2017 Aug; 9(16):1227-1235. PubMed ID: 28766381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a competitive binding homogeneous mobility shift assay for the quantification of adalimumab levels in patient serum.
    Hock BD; Smith SM; McEntyre CJ; McKenzie JL; Sies C; Keating PE
    J Immunol Methods; 2019 Nov; 474():112672. PubMed ID: 31525368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous Absorption Contributes to Observed Interindividual Variability in Adalimumab Serum Concentrations in Crohn's Disease: A Prospective Multicentre Study.
    Vande Casteele N; Baert F; Bian S; Dreesen E; Compernolle G; Van Assche G; Ferrante M; Vermeire S; Gils A
    J Crohns Colitis; 2019 Sep; 13(10):1248-1256. PubMed ID: 30820530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An enzyme-linked immunosorbent assay for therapeutic drug monitoring of cetuximab.
    Cézé N; Ternant D; Piller F; Degenne D; Azzopardi N; Dorval E; Watier H; Lecomte T; Paintaud G
    Ther Drug Monit; 2009 Oct; 31(5):597-601. PubMed ID: 19730278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring of adalimumab and antibodies-to-adalimumab levels in patient serum by the homogeneous mobility shift assay.
    Wang SL; Hauenstein S; Ohrmund L; Shringarpure R; Salbato J; Reddy R; McCowen K; Shah S; Lockton S; Chuang E; Singh S
    J Pharm Biomed Anal; 2013 May; 78-79():39-44. PubMed ID: 23454676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An enzyme-linked immunosorbent assay to study bevacizumab pharmacokinetics.
    Ternant D; Cézé N; Lecomte T; Degenne D; Duveau AC; Watier H; Dorval E; Paintaud G
    Ther Drug Monit; 2010 Oct; 32(5):647-52. PubMed ID: 20720519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simple and cost-effective assay for measuring anti-drug antibody in human patients treated with Adalimumab.
    Li M; Li H; Gao K; Wang M; An W; Zhu Y; Ding L; Wang L; Gu J; Zuo C; Sun L
    J Immunol Methods; 2018 Jan; 452():6-11. PubMed ID: 29037956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous Quantification of Adalimumab and Infliximab in Human Plasma by Liquid Chromatography-Tandem Mass Spectrometry.
    Jourdil JF; Némoz B; Gautier-Veyret E; Romero C; Stanke-Labesque F
    Ther Drug Monit; 2018 Aug; 40(4):417-424. PubMed ID: 29608486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of monoclonal antibodies for measuring Avastin and its biosimilar by Sandwich ELISA.
    Li M; An W; Wang L; Zhang F; Li J; Zhang Y; Li Y; Li H; Ren W; Zhao R; Xia C; Sun L
    J Immunol Methods; 2019 Jun; 469():42-46. PubMed ID: 30943379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of both versions of an immunoassay commercialized for therapeutic drug monitoring of adalimumab in rheumatoid arthritis.
    Llinares-Tello F; Rosas J; de la Torre I; Valor L; Barber X; Senabre JM;
    Reumatol Clin; 2014; 10(2):105-8. PubMed ID: 24035361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of a Drug-Resistant Anti-Adalimumab Antibody Assay to Monitor Immunogenicity in the Presence of High Concentrations of Adalimumab.
    Bian S; Ferrante M; Gils A
    AAPS J; 2017 Mar; 19(2):468-474. PubMed ID: 27873119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and analytical validation of an enzyme-linked immunosorbent assay for the measurement of feline tumor necrosis factor α in serum.
    Steiner JM; Xenoulis PG; Schwierk VM; Suchodolski JS
    Vet Clin Pathol; 2014 Sep; 43(3):397-404. PubMed ID: 24976216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of bioanalytical methods for the quantitation of PEGylated human insulin.
    de Dios K; Manibusan A; Marsden R; Pinkstaff J
    J Immunol Methods; 2013 Oct; 396(1-2):1-7. PubMed ID: 23933323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of a new rapid method for the determination of adalimumab serum levels with two established ELISA kits.
    Laserna-Mendieta EJ; Salvador-Martín S; Arias-González L; Ruiz-Ponce M; Menchén LA; Sánchez C; López-Fernández LA; Lucendo AJ
    Clin Chem Lab Med; 2019 Nov; 57(12):1906-1914. PubMed ID: 31085742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infliximab and Adalimumab Concentrations May Vary Between the Enzyme-Linked Immunosorbent Assay and the Homogeneous Mobility Shift Assay in Patients With Inflammatory Bowel Disease: A Prospective Cross-Sectional Observational Study.
    Clarke WT; Papamichael K; Vande Casteele N; Germansky KA; Feuerstein JD; Melmed GY; Siegel CA; Irving PM; Cheifetz AS
    Inflamm Bowel Dis; 2019 Oct; 25(11):e143-e145. PubMed ID: 31559417
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.